Burning Rock Biotech Ltd. ADR (BNR) Social Stream



Burning Rock Biotech Ltd. ADR (BNR): $7.55

0.02 (-0.26%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

BURNING ROCK BIOTECH LTD (BNR) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering BNR.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-25 3 $36.1 $27.5 $31.8 $0.924 3341.56%
2021-12-06 3 $36.1 $23 $29.55 $0.924 3098.05%
2022-01-06 3 $26.7 $23 $24.85 $0.924 2589.39%
2022-03-17 3 $26.7 $13.5 $20.1 $0.924 2075.32%
2022-03-23 3 $26.7 $13 $19.85 $0.924 2048.27%
2022-03-25 3 $13 $12.8 $12.9 $0.924 1296.1%
2022-08-13 3 $12.8 $6.7 $9.75 $0.924 955.19%
2022-09-26 3 $10.8 $6.7 $8.75 $0.924 846.97%
2023-01-26 3 $10.8 $3.8 $7.3 $0.924 690.04%
2023-03-29 1 $8.9 $8.9 $8.9 $0.924 863.2%
2023-05-16 2 $8.9 $3.8 $6.35 $0.924 587.23%
2023-09-01 1 $7.3 $7.3 $7.3 $0.924 690.04%
2023-09-22 1 $0.9 $0.9 $0.9 $0.924 -2.6%

The Trend in the Analyst Price Target


Over the past 34 months, BNR's average price target has gone down $31.2.

BNR reports an average of 157.72% for its upside potential over the past 34 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-26 2 10.8 3.8 7.30 3.17 130.28%
2023-01-26 3 10.8 3.8 7.30 3.17 130.28%
2023-03-29 1 8.9 8.9 8.90 2.90 206.9%
2023-03-29 2 8.9 8.9 8.90 2.90 206.9%
2023-05-16 2 8.9 3.8 6.35 2.82 125.18%

BNR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 1 0 0 1

The Trend in the Broker Recommendations


Over the past 35 weeks, BNR's average broker recommendation rating worsened by 2.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BNR as an investment opportunity.

  • BNR has a greater upside potential (average analyst target price relative to current price) than 1388.57% of all US stocks.
  • In the context of all US stocks, BURNING ROCK BIOTECH LTD's number of analysts covering the stock is higher than 79.46% of them.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, BURNING ROCK BIOTECH LTD's variance in analysts' estimates is lower than -611.68% of them.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, BURNING ROCK BIOTECH LTD's average analyst price target is greater than 287.87% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Healthcare industry with the ratings most similar to BURNING ROCK BIOTECH LTD are GTH, CANO, and SGRY.

What is the outlook for BNR? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!